Furthermore, pre-clinical studies have already demonstrated therapeutic targeting of lncRNAs, such as MALAT1 and HOXB-AS3 in cancer (Arun et al., 2016; Papaioannou et al., 2019), suggesting their potential clinical value in cancer diagnosis and treatment. Here, MALAT1 is linked to cancer.